The role of tetracycline-impregnated fibers in retreatment

Periodontology 2000

Volumn 12, Issue 1, 1996, Pages 133-140

  Greenstein, Gary ^a   Rethman, Mike ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DRUG CARRIER; ETHYLENEVINYLACETATE COPOLYMER; POLYVINYL DERIVATIVE; TETRACYCLINE;

HUMAN; PATIENT SELECTION; PERIODONTITIS; RECURRENT DISEASE; RETREATMENT; REVIEW;

ANTI-BACTERIAL AGENTS; DRUG CARRIERS; HUMANS; PATIENT SELECTION; PERIODONTAL POCKET; PERIODONTITIS; POLYVINYLS; RECURRENCE; RETREATMENT; TETRACYCLINE;

EID: 0030251975     PISSN: 09066713     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0757.1996.tb00091.x     Document Type: Article

References (36)

1. Actisite®, Procter and Gamble/Alza Corp. Palo Alto, CA, USA. Product insert.
2. Ciancio SC. Review: other studies with Actisite fiber. Biol Ther Dent 1994: 10: 12.
3. Ciancio SG, Cobb CM, Leung M. Tissue concentration and localization of tetracycline following site specific tetracycline fiber therapy. J Periodontol 1992: 63: 849-853.
4. Corsair A. Long-term effect of tetracycline fibers on recurrent lesions in periodontal maintenance patients. Periodontol Clin Invest 1994: 16: 8-13.
5. Drisko CL, Cobb CM, Killoy WJ, Michalowicz BS, Pihlstrom BL, Lowenguth RA, Caton JG, Encarnacion M, Knowles M, Goodson JM. Evaluation of periodontal treatments using controlled-releasë tetracycline fibers: Clinical response. J Periodontol 1995: 66: 692-699.
6. Goodson JM. Controlled drug delivery: a new means of treatment of dental diseases. Compendium 1985: 6: 27-36.
7. Goodson MA, Cugini RL, Kent GC, Armitage GC, Cobb CM, Fine D. Multicenter evaluation of tetracycline fiber therapy. II. Clinical response. J Periodont Res 1991: 26: 371-379.
8. Goodson JM, Hogan P, Dunham S. Clinical responses following periodontal treatment by local drug delivery. J Periodontol 1985: 56: 81-87.
9. Goodson JM, Holborow D, Dunn RL, Hogan P. Dunham S. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets. J Periodontol 1983: 54: 575-579.
10. Goodson JM, Offenbacher S, Farr DH, Hogan PE. Periodontal disease treatment by local drug delivery. J Periodontol 1985: 56: 265-272.
11. Goodson JM, Tanner A. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy. Oral Microbiol Immunol 1992: 7: 113-117.
12. Goodson JM, Tanner A, McArdle S. Dix K, Watanabe SM. Multicenter evaluation of tetracycline fiber therapy. III. Microbiological response. J Periodont Res 1991: 26: 440-451.
13. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline levels achievable in gingival crevice fluid and in vitro effect on subgingival organisms. Part I. J Periodontol 1981: 52: 609-661.
14. Greenstein G. Diagnosis of periodontal diseases. Compendium 1994: 15: 750-801.
15. Greenstein G. Periodontal response to mechanical nonsurgical therapy. J Periodontol 1992: 63: 118-130.
16. Heijl L, Dahlén G, Sundin Y, Wenander A, Goodson JM. A 4 quadrant comparative study of periodontal treatment using tetracycline containing drug delivery fibers and scaling. J Clin Periodontol 1991: 18: 111-116.
17. Hoffler U, Niederau W, Pulverer G. Susceptibility of bacterium Actinobacillus actinomycetemcomitans to 45 antibiotics. Antimicrob Agents Chemother 1980: 17: 943-946.
18. Kaldahl WB, Kalkwarf KL, Patil KD. A review of longitudinal studies that compared periodontal therapies. J Periodontol 1993: 64: 243-253.
19. Kerry G. Tetracycline-loaded fibers as adjunctive treatment in periodontal disease. J Am Dent Assoc 1994: 125: 1199-1203.
20. Killoy WJ. Controlled local drug delivery of antimicrobials in the treatment of periodontitis. In: McGuire M, Townsend C, ed. Periodontal disease management. Chicago: American Academy of Periodontology, 1994: 221-236.
21. Lindhe J, Heijl L, Goodson JM, Socransky SS. Local tetracycline delivery using hollow fiber devices in periodontal therapy. J Clin Periodontol 1979: 6: 141-149.
22. Lowenguth RA, Chin I, Caton JG, Cobb CM, Drisko CL, Killoy WJ, Michalowicz BS, Pihlstrom BL, Goodson JM. Evaluation of periodontal treatments using controlled- release tetracycline fibers: microbiological response. J Periodontol 1995: 66: 700-707.
23. Maiden MFJ, Tanner A, McArdle S, Najpauer K, Goodson JM. Tetracycline fiber therapy monitored by DNA probe and cultural methods. J Periodont Res 1991: 26: 452-459.
24. Mandell R, Tripodi L, Savitt E, Goodson J, Socransky S. The effect of treatment on Actinobacillus actinomycetemcomitans in localized juvenile periodontitis. J Periodontol 1986: 57: 94-97.
25. Michalowicz BS, Pihlstrom BL, Drisko CL, Cobb CM, Killoy WJ, Caton JG, Lowenguth RA, Quin̄ones C, Encarnacion M, Knowles M, Goodson JM. Evaluation of periodontal treatments using controlled-release tetracycline fibers: maintenance response. J Periodontol 1995: 66: 708-715.
26. Neu HC. The crisis in antibiotic resistance. Science 1992: 257: 1064-1073.
27. Newman MG, Kornman KS, Doherty FM. A 6-month multicenter evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: clinical results. J Periodontol 1994: 65: 685-691.
28. Preus HR, Lassen J, Aass AM, Ciancio SG. Bacterial resistance following subgingival and systemic administration of minocycline. J Clin Periodontol 1995: 22: 380-384.
29. Proceedings of the World Workshop in Periodontics. Chicago, IL: American Academy of Periodontology, 1989.
30. Rams TE, Slots J. Antibiotics in periodontal therapy: an update. Compendium 1992: 8: 1130-1145.
31. Rapley JW, Cobb CM, Killoy WJ, Williams DR. Serum levels of tetracycline during treatment with tetracycline fibers. J Periodontol 1992: 63: 817-820.
32. Rodenbury JP, van Winkelhoff AJ, Winkel EG, Goene RJ, Abbas F, de Graaff J. Occurrence of Bacteroides gingivalis, Bacteroides intermedius and Actinobacillus actinomycetemcomitans in severe periodontitis in relation to age and treatment history. J Clin Periodontol 1990: 17: 392-399.
33. Slots J, Evans TE, Lobbins PM, Genco FJ. In vitro antimicrobial susceptibility of Actinobacillus actinomycetemcomitans. Antimicrob Agents Chemother 1980: 18: 9-12.
34. Socransky SS, Haffajee AD. Effect of therapy in periodontal infections. J Periodontol 1993: 64: 754-759.
35. Sutter VL, Jones MJ, Ghoneium ATM. Antimicrobial susceptibility of bacteria associated with periodontal diseases. Antimicrob Agents Chemother 1983: 23: 483-486.
36. Tonetti M, Cugini MA, Goodson JM. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers. J Periodont Res 1990: 25: 243-249.